KIT and Hypertension: The observation that a third of patients with CKD aetiology due to hypertension or diabetes also have a strong immune/inflammatory milieu as part of their renal injury suggests that appreciation of the biological heterogeneity of different categorical diseases by the individual biomarker values in the KIT assay, and other interrogative studies, will allow for more customized approaches to treatment for CKD patients.